Monoclonal antibodies, developed 25 years ago, are now being explored for new therapeutic applications by researchers and biotech firms. Current efforts focus on advancing these promising biological drugs.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Discussion:
Key Insights:
Outlook: